Quantum Design names Matt Gorovoy chief commercial officer

Quantum Design has appointed Matt Gorovoy as chief commercial officer, effective July 15, 2026, as the San Diego-based scientific instrumentation company pushes for global growth and strategic expansion. Gorovoy joins from Becton Dickinson and will oversee sales, marketing, business development and commercial strategy.

Why it matters: - Quantum Design is adding a senior commercial leader as it tries to accelerate global growth across quantum technologies, advanced materials, semiconductors, energy and the physical sciences. - The move puts a leader with experience in life sciences, diagnostics and scientific instrumentation in charge of customer-facing functions that can shape revenue growth and partnership expansion. - Quantum Design is also pursuing strategic acquisitions and new growth opportunities, making commercial execution more important.

What happened: - Quantum Design named Matt Gorovoy chief commercial officer, effective July 15, 2026. - Gorovoy will report to Chief Executive Officer Stuart Schoenmann and join the company’s Executive Leadership Team. - The company announced the appointment on July 20, 2026.

The details: - Gorovoy will lead Quantum Design’s global commercial organization. - His remit includes sales, marketing, business development, commercial strategy and related customer-facing functions. - His responsibilities include accelerating global growth, strengthening commercial excellence, expanding strategic partnerships and supporting organic and acquisition-driven growth initiatives. - Quantum Design said Gorovoy brings more than two decades of leadership experience across life sciences, diagnostics, scientific instrumentation and advanced technology industries. - At Becton Dickinson, he led Business Development and Strategy for BD Biosciences. - His BD role included global business development, strategic partnerships, precision medicine initiatives and corporate development. - He helped lead the strategic divestiture of BD Biosciences and its subsequent combination with Waters Corporation. - At Danaher Corporation, Gorovoy held executive roles in Corporate Science & Technology and the Diagnostics Platform. - He helped establish Danaher’s Precision Medicine platform and led strategy, operations, business development and strategic investments across multiple operating companies. - At Thermo Fisher Scientific, he spent about a decade in general management and commercial leadership roles. - His Thermo Fisher work included global P&Ls, commercial strategy and growth initiatives across diagnostics and life sciences businesses. - Gorovoy holds an MBA from the University of California San Diego, a Ph.D. in Pharmacology from the University of Illinois Chicago and an M.S. in Organic Chemistry from Moscow State University. - Quantum Design International is a provider of scientific instrumentation for materials characterization, low-temperature measurement and quantum computing. - The company serves academic, government and industrial laboratories worldwide. - Quantum Design is a portfolio company of Carlson Private Capital. - Quantum Design’s social media page is available here.

Between the lines: - The appointment signals a focus on commercial scale, not just technical innovation. - Schoenmann’s comments point to a push for stronger customer relationships, broader global reach and more disciplined execution as Quantum Design enters its next growth phase. - Gorovoy’s background suggests Quantum Design is prioritizing leaders who can connect strategy, partnerships and corporate development.

What's next: - Gorovoy is expected to help expand Quantum Design’s commercial footprint and support future growth initiatives. - The company is likely to keep investing in innovation, global expansion and acquisitions as it builds on the new leadership structure. - Quantum Design will now test whether this commercial leadership change translates into faster growth and deeper strategic partnerships.